Showing results (841-850 of 895) with videos related to

Sort By:
Pageof 90
Cell Death & Disease|November 7, 2020
SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolismAnna Polak, Emilia Bialopiotrowicz, Beata Krzymieniewska, et al.
Molecular Therapy. Oncology|May 25, 2026
Neural stem cell delivery of oncolytic CRAd-S-pk7 immunotherapy for stage 3 ovarian cancer: Dose-regimen studiesRachael Mooney, Gary Ngai, Gurmeet Kaur, et al.
Pharmacology & Therapeutics|August 25, 2010
The development of MDA-7/IL-24 as a cancer therapeuticPaul Dent, Adly Yacoub, Hossein A Hamed, et al.
The American Journal of Sports Medicine|October 17, 2025
Risk Profile for Cyclops Syndrome Necessitating Reoperation After Anterior Cruciate Ligament ReconstructionTing Cong, Sahil Dadoo, Jumpei Inoue, et al.
NPJ Breast Cancer|February 10, 2026
Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxaneMarcin Kubeczko, Sandra Cobo, Rodrigo Sanchez-Bayona, et al.
Journal of Hepatology|September 10, 2022
Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humansTiong Y Lim, Elena Perpiñán, Maria-Carlota Londoño, et al.
Environmental Science & Technology|July 17, 2009
Fate and effects of CeO2 nanoparticles in aquatic ecotoxicity testsKaren Van Hoecke, Joris T K Quik, Joanna Mankiewicz-Boczek, et al.
European Journal of Medicinal Chemistry|December 30, 2014
Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist - neurokinin-1 antagonist peptidomimeticsKarel Guillemyn, Patrycia Kleczkowska, Anna Lesniak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2020
CD8+ T-cell-Mediated Immunoediting Influences Genomic Evolution and Immune Evasion in Murine GliomasJoshua R Kane, Junfei Zhao, Takashi Tsujiuchi, et al.
The Lancet. Oncology|May 4, 2023
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trialAdam M Sonabend, Andrew Gould, Christina Amidei, et al.
Pageof 90